biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > End is Nearing Fast

<< Previous

Bullboard Posts

Next >>

Comment by MBT123on May 20, 2022 6:56pm

173 Views

Post# 34699782

RE:RE:RE:RE:RE:RE:End is Nearing Fast

Any guesses as too what the SP will be when Dr.R flies over for the funeral in Vancouver first week of June?? With the big ask dropping a few pennies every week she may get it down to a dime! She must be so proud!! All that part-time CEO work is really showing up in the market...Haha Chances are she won't even be able to afford to fly over and have to hold the funeral over zoom or something.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages